| 000 | 01241 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513211024.0 | ||
| 264 | 0 | _c20000707 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a1064-1963 | ||
| 024 | 7 |
_a10.1081/ceh-100100076 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmit, A J | |
| 245 | 0 | 0 |
_aDopamine in heart failure and critical care. _h[electronic resource] |
| 260 |
_bClinical and experimental hypertension (New York, N.Y. : 1993) _cApr 2000 |
||
| 300 |
_a269-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 |
_aCritical Care _xmethods |
| 650 | 0 | 4 |
_aDeoxyepinephrine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDopamine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aFenoldopam _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tClinical and experimental hypertension (New York, N.Y. : 1993) _gvol. 22 _gno. 3 _gp. 269-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/ceh-100100076 _zAvailable from publisher's website |
| 999 |
_c10755626 _d10755626 |
||